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ABSTRACT
Introduction Evidence from previous pandemics, and 
the current COVID-19 pandemic, has found that risk of 
infection/severity of disease is disproportionately higher for 
ethnic minority groups, and those in lower socioeconomic 
positions. It is imperative that interventions to prevent 
the spread of COVID-19 are targeted towards high- risk 
populations. We will investigate the associations between 
social characteristics (such as ethnicity, occupation and 
socioeconomic position) and COVID-19 outcomes and the 
extent to which characteristics/risk factors might explain 
observed relationships in Scotland.
The primary objective of this study is to describe the 
epidemiology of COVID-19 by social factors. Secondary 
objectives are to (1) examine receipt of treatment and 
prevention of COVID-19 by social factors; (2) quantify 
ethnic/social differences in adverse COVID-19 outcomes; 
(3) explore potential mediators of relationships between 
social factors and SARS- CoV-2 infection/COVID-19 
prognosis; (4) examine whether occupational COVID-19 
differences differ by other social factors and (5) assess 
quality of ethnicity coding within National Health Service 
datasets.
Methods and analysis We will use a national cohort 
comprising the adult population of Scotland who 
completed the 2011 Census and were living in Scotland 
on 31 March 2020 (~4.3 million people). Census data 
will be linked to the Early Assessment of Vaccine and 
Anti- Viral Effectiveness II cohort consisting of primary/
secondary care, laboratory data and death records. 
Sensitivity/specificity and positive/negative predictive 
values will be used to assess coding quality of ethnicity. 
Descriptive statistics will be used to examine differences 
in treatment and prevention of COVID-19. Poisson/
Cox regression analyses and mediation techniques will 
examine ethnic and social differences, and drivers of 
inequalities in COVID-19. Effect modification (on additive 
and multiplicative scales) between key variables (such as 
ethnicity and occupation) will be assessed.
Ethics and dissemination Ethical approval was obtained 
from the National Research Ethics Committee, South 
East Scotland 02. We will present findings of this study at 
international conferences, in peer- reviewed journals and to 
policy- makers.
INTRODUCTION
Historically, pandemics have dispropor-
tionately affected specific groups within 
the population. For example, during the 
Spanish influenza pandemic of 1918, indi-
viduals from poorer socioeconomic positions 
(SEP) experienced higher incidence of influ-
enza in the USA.1 These findings have been 
replicated in various international settings 
using data from the 1918 pandemic.2 Similar 
patterns were observed following the H1N1 
influenza pandemic in 2009 in Canada, with 
an increased risk of hospitalisation among 
Strengths and limitations of this study
 ► This study uses a near- complete cohort of the 
Scottish population, providing considerable sta-
tistical power to investigate social inequalities in 
COVID-19.
 ► Linkage of the Scottish Census to administrative 
data allows for evaluation of differences in COVID-19 
across specific occupational classes, which is not 
available in any other dataset in Scotland.
 ► Given the Census data are from 2011 and are being 
linked to data from 2020 to 2021, some occupation-
al and social data may be out of date.
 ► Individuals who moved to Scotland post- Census will 
not be included in all analyses, for the same reasons 
as above.
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individuals with lower educational attainment or resident 
in areas of greater deprivation.3 English data demon-
strated a socioeconomic gradient in mortality during the 
2009 pandemic, with the highest risk of death observed in 
those living in deprived areas.4 5 Ethnicity was also identi-
fied as a risk factor for mortality during the 2009 pandemic, 
with those in non- White ethnic groups at increased risk 
of mortality from H1N1 influenza compared with White 
populations in the UK.5 The mechanisms underlying 
these socio- economic patterns have been hypothesised as 
resulting from a combination of different exposure and 
susceptibility to infection, and differing access to health-
care services.6 Understanding the role of ethnic, socio-
economic and occupational risk factors in both risk and 
outcome of infection during a pandemic is essential for 
health service planning, targeting preventative measures 
and informing future modelling efforts.
The SARS- CoV-2 and its resulting disease (COVID-19) 
is spreading rapidly worldwide, causing a high burden of 
mortality and morbidity.7 The differential risks of infec-
tion in ethnic minority groups have been examined 
during the COVID-19 pandemic.8 Epidemiological anal-
yses within England have found higher risks among some 
minority ethnic groups, both for risk of infection and for 
the consequences of infection.9–13 These findings have 
been supported by international evidence, which suggests 
individuals from Black and South Asian ethnic groups are 
at increased risk of experiencing COVID-19 and its resul-
tant harms.12 14
Emerging evidence suggests that marked socio- 
economic inequalities in risk and outcome of COVID-19 
exist, yet empirical evidence describing the role of socio- 
economic factors in Scotland is limited.11 Initial analyses 
in Scotland have been subject to considerable misclassifi-
cation of ethnicity (due to systematically incomplete data 
within health records) and limited by using a broad three- 
category classification of ethnicity in a small case–control 
sample15; however, survey- based research with more 
specific ethnicity classifications has suggested that ethnic 
minorities may be more hesitant to be vaccinated against 
COVID-19.16 Analyses have therefore shown inconsistent 
findings. Understanding how sociodemographic factors 
are related to infection risk and prognosis, as well as 
monitoring inequalities by area level (such as indices of 
multiple deprivations) and individual/household- level 
(such as social class or household tenure) SEP, is essential 
for health service planning, targeting prevention efforts 
and informing future modelling efforts. In addition, our 
understanding of why inequalities in COVID-19 outcomes 
exist remain limited.17 For example, differences in occu-
pation, household composition and healthcare could 
operate as important mediating mechanisms, which 
could potentially be targeted to mitigate ethnic inequali-
ties in COVID-19.
The Early Assessment of Vaccine and Anti- Viral Effec-
tiveness II (EAVE II) study18–20 is an ongoing project which 
tracks the epidemiology of COVID-19 in Scotland in real 
time, and aims to evaluate the effectiveness of future 
vaccinations in reducing spread of the infection. While 
the main EAVE II project will stratify COVID-19 rates and 
vaccine effectiveness by demographic characteristics such 
as age and region, it will not examine the role of ethnicity 
and social factors in detail. Linkage of the EAVE II dataset 
to other administrative sets, in particular the 2011 Scot-
land Census, allows the assessment of the role of social 
and ethnic inequalities on risk of SARS- CoV-2 infection 
and subsequent disease outcomes. This provides better 
understanding of groups at higher risk from COVID-19 
within the Scottish population compared with adminis-
trative data sources (which typically lack detailed infor-
mation about social characteristics), yielding valuable 
information for clinicians and healthcare planners as 
the pandemic continues to evolve. Learning from this 
pandemic may also yield longer term lessons for public 
health policy.
Aim and objectives
This EAVE II substudy aims to quantify social inequalities 
in COVID-19 related outcomes in Scotland using linked 
census and administrative data, as well as examining the 
mechanisms through which inequalities in COVID-19 
arise.
Our primary objective is to describe the epidemiology 
of COVID-19 by: (1) ethnicity, (2) SEP, (3) occupation 
and (4) residential circumstances.
In addition, we have five secondary objectives:
1. To monitor receipt of COVID- related treatment and 
preventive interventions across social and ethnic 
groups.
2. To quantify ethnic and social differences in the risk of 
adverse outcomes (hospital admission, critical care ad-
mission and mortality) from COVID-19.
3. To explore the potential contribution of pre- existing 
health conditions and risk factors to ethnic and social 
inequalities in COVID-19 and prognosis.
4. To investigate if occupational (and potentially socio-
economic or ethnic) differences in COVID-19 risks are 
modified by other social factors.
5. To assess the quality of ethnicity coding within National 
Health Service (NHS) administrative datasets.
Secondary objective b will be examined for three 
groups defined by experiencing: (1) laboratory 
confirmed SARS- CoV-2 infection, (2) clinically diagnosed 
SARS- CoV-2 infection and (3) serological evidence of 
previous infection with SARS- CoV-2.
METHODS AND ANALYSIS
Study design and population
We will perform analyses on a national prospective cohort 
of the Scottish population, including all individuals who 
meet the following criteria: (1) alive on the 1 March 2020; 
(2) resident in Scotland on that date and (3) present in 
the 2011 Census in Scotland. A start date of 1 March 2020 
has been selected as the first case of laboratory confirmed 
SARS- CoV-2 in Scotland was identified on 2 March 2020.21 
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Analyses will focus on the adult population aged 16 
years and over, with some analyses limited to older age 
groups (eg, aged 25+ years on the Census 2011 date when 
analysing highest education level). We will also conduct 
analyses that include individuals not present in the 2011 
Census when they are of specific policy interest—for 
example, to look at vaccination uptake.
Databases
The Community Health Index (CHI) is a unique numer-
ical identifier, assigned to every individual registered 
to receive healthcare in Scotland, which can be used to 
identify and link all healthcare interactions and records 
for an individual.22 Linkage of these administrative data-
sets with the 2011 Census data will allow the examina-
tion of clinically diagnosed and laboratory confirmed 
SARS- CoV-2 infection, deaths and potential confounders 
(figure 1). The CHI is mandatory for anyone receiving 
medical treatment.22 Furthermore, individuals known to 
have emigrated (through general practice (GP) dereg-
istration) prior to the pandemic will be excluded. Data 
linkage and analyses will take place within the National 
Safe Haven, a secure and trusted research environment.23
Census
In Scotland, the national Census is conducted every 
10 years by means of a mandatory survey sent to every 
household in the country.24 The most recent Census 
was conducted in 2011 and forms the population spine 
of our cohort. The census extract for this study contains 
demographic information including ethnic group, reli-
gion and country of birth, marital status, SEP indicators 
such as highest educational attainment, employment 
status and occupation, household information including 
persons per room, tenure and number of cars and vari-
ables on prepandemic health status identifying long- term 
illnesses and disability status. Census data are necessary 
to identify our exposures of interest, as well as to study 
potential mediating pathways and effect modification. 
The necessary information required from the Census 
(eg, ethnicity, occupation) is not reliably available from 
other sources. While ethnicity is recorded in some health 
datasets in Scotland, it is often missing, reported inconsis-
tently across datasets, and not always based on self- report, 
which is considered the gold standard for establishing 
ethnicity.25
Laboratory data
To identify individuals with confirmed SARS- CoV-2 infec-
tion, positive viral reverse transcriptase PCR (RT- PCR) 
results will be confirmed using Electronic Communica-
tion of Surveillance in Scotland (ECOSS) data, a national 
repository of diagnostic and reference laboratory data on 
testing for viral infections including COVID-19.26 To iden-
tify individuals with serologically confirmed infection, 
Figure 1 Data flow diagram for linkage of census and administrative data comprising cohort blue box: census data yellow 
box: administrative data green box: linked data dark background: data processing. A&E, Accident and Emergency; CHI, 
Community Health Index; CO- CIN, COVID-19 Clinical Information Network; EAVE II, Early Assessment of Vaccine and Anti- Viral 
Effectiveness II; ECOSS, Electronic Communication of Surveillance in Scotland; eDRIS, electronic Data Research Innovation 
Service; GP, general practice; HEPMA, Hospital Electronic Prescribing and Medicines Administration; ISARIC, International 
Severe Acute Respiratory and Emerging Infection Consortium; NHS, National Health Service; NRS, National Records for 
Scotland; PIS, Prescribing Information System; RAPID, Rapid Preliminary Inpatient Data; SAS, Scottish Ambulance Service; 
SICSAG; Scottish Intensive Care Society Audit Group; SMR, Scottish Morbidity Records.
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serology data will be provided via the Enhanced Surveil-
lance of COVID-19 in Scotland (ESoCiS) programme 
undertaken by Public Health Scotland (PHS) on behalf 
of the Scottish Government.27
Secondary care
The Scottish Morbidity Record (SMR), maintained 
by PHS, is the primary repository for data describing 
hospital admissions in Scotland.28 We will use data from 
SMR01, which details general inpatient admissions, 
and SMR02, which details obstetric admissions. We will 
include data from the Rapid Preliminary Inpatient Data 
(RAPID) dataset. The RAPID data are collected quickly, 
in an unprocessed state and are therefore available more 
quickly than SMR data,29 which is necessary given the 
pertinent nature of our study. Data about intensive care 
unit admissions in adults will be included by linking data 
from the Scottish Intensive Care Society Audit Group 
(SICSAG).30 These datasets use International Classifi-
cation of Diseases (ICD-10) codes to record an individ-
ual’s diagnoses. ICD-10 codes will be used to identify a 
clinical diagnosis of COVID-19 in the absence of a posi-
tive test result for those admitted to hospital with diag-
nosed COVID-19. Scottish Ambulance Service (SAS) and 
Accident and Emergency (A&E) records, also provided 
by PHS, will be used to identify people with clinically 
suspected COVID-19.
The prescribing information system (PIS) is the 
repository for all prescriptions requested for individ-
uals by general practices,31 and the Hospital Electronic 
Prescribing and Medicines Administration (HEPMA) 
is the equivalent for prescribing and administration of 
medicine in a hospital setting.32 Both of these datasets 
use the British National Formulary (BNF), a standardised 
medication classification system.33 We will use BNF codes 
to identify prescribed drugs or administered medicine 
used to treat COVID-19, identify comorbidities (such as 
diabetes and hypertension) and allow the study of longer- 
term consequences of COVID-19.
Primary care
Just under 100% of the population of Scotland is regis-
tered with a GP, which provides free- at- point- of- delivery 
primary healthcare services.34 NHS 24 is the Scottish 
national telephone service for the general public, which 
provides clinical triage and advice for those experiencing 
non- critical ill health during the out- of- hours period. 
This was expanded to provide advice to individuals with 
suspected COVID-19 at any time during the pandemic.35 
We will use GP consultation data and NHS24 out- of- hours 
data to identify clinically suspected COVID-19. In addi-
tion, data from the recently established COVID-19 clinical 
assessment centres will also be included for this purpose.
Deaths
National Records for Scotland (NRS) provides data about 
deaths attributed to COVID-19, which will be included 
in our dataset.36 ICD-10 codes will be used to identify 
deaths occurring in individuals with clinically confirmed 
COVID-19 within 28 days of death (U07.1, U07.2).
Exposures and covariates
We will examine four categories of social factors in rela-
tion to the study’s primary outcomes: ethnicity, SEP, 
occupation and residential circumstances. Ethnicity 
will be categorised based on standard Census classifi-
cations,37 self- reported in sixteen groups. We will try to 
analyse ethnicity using as detailed categorisations as 
possible, subject to having adequate numbers for mean-
ingful statistical analysis. SEP will be classified at both 
area level (the Scottish Index of Multiple Deprivation 
(SIMD)) and individual level (eg, education level and 
housing tenure). The SIMD is a measure of the relative 
deprivation of broadly heterogeneous population level 
‘data zones’ within Scotland, classifying deprivation using 
the following weighted domains: employment, income, 
health, crime, housing, education and access to services.38 
The SIMD is typically operationalised using either quin-
tiles or deciles, with quintile/decile 1 referring to the 
most deprived 20% or 10% of the population, respec-
tively. Marital status will consist of five categories as per 
the Census: single (never married), married, separated, 
divorced and widowed.39 Housing tenure will consist of 
seven categories as per the Census: owned (outright), 
owned (mortgage), social rented (council), social rented 
(other), private rented (landlord/letting agency), private 
rented (other/rent- free) or communal.40 Occupation will 
be measured using the Standard Occupational Classifica-
tion 2000, consisting of major, submajor, minor and unit 
group levels.41 Employment status, weekly hours worked 
and type of industry (coded using Standardised Industrial 
Classification, SIC) will be used to explore potential differ-
ential workplace exposure. Residential circumstances will 
be classified using the following parameters: housing 
tenure, persons per room, household size and age range 
of household (difference between oldest and youngest 
permanent occupant).
The following additional characteristics will be used to 
address confounding, explore mediation and for assessing 
effect modification. Cultural factors will be investigated, 
including religion, and English language ability via a four- 
point Likert scale (very well, well, not well, not at all). 
Geographical variables will include 32 local authorities 
(LA) comprising local government in Scotland. While 
these LA have some devolved powers, primarily in service 
provision,42 the most pertinent local factor for this study 
is that COVID-19 mitigation levels are, at the time of 
writing, allocated by a LA- level tiering system.43 We will 
explore the role of rurality using the Scottish Govern-
ment Urban Rural Classification, which can be used as 
a simple two- fold measure (defining ‘rurality’ as areas 
with a population of <3000) at its simplest, or an eight-
fold measure at its most complex).44 Prepandemic health 
status will be assessed on the basis of general self- reported 
health, captured using a five- point Likert scale (very 
good, good, fair, bad, very bad), and the presence of the 
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following additional self- reported health circumstances 
as recorded in the Census: long- term condition, mental 
health condition, other condition, hearing impairment, 
visually impairment, learning disability, developmental 
disorder, and physical disability. Behavioural risk factors 
(such as smoking status and body mass index) and health 
conditions (including pregnancy) will also be identified 
from GP and hospital data.
Outcome definitions
The primary outcomes of this study will be laboratory 
confirmed SARS- CoV-2 infection, clinically diagnosed 
COVID-19 and serologically confirmed evidence of 
previous SARS- CoV-2 infection. Laboratory confirmed 
SARS- CoV-2 infection will be defined as positive RT- PCR via 
the ECOSS dataset. Serologically confirmed SARS- CoV-2 
infection will be defined as positive antibodies on serology 
testing as identified through ESoCiS data, reflecting 
immunological evidence of previous infection. Clini-
cally diagnosed COVID-19 disease will be defined as the 
requisite ICD-10 code being recorded on discharge from 
hospital via SMR, intensive care via SICSAG, or on NRS 
death records. Clinically suspected COVID-19 disease 
will be used as a secondary outcome in the absence of 
laboratory confirmed COVID-19 and recorded via SAS or 
A&E attendance records, GP consultation or out- of- hours 
records, COVID-19 clinical assessment centre data, or 
NHS 24 logs. Given testing practices are changing over 
time, we will conduct sensitivity analyses by stratifying 
analyses by time period and consider weighting analyses 
to account for differential testing practices.
Secondary outcomes include uptake of vaccina-
tion for COVID-19, as recorded in GP records or the 
vaccine delivery app, and being prescribed treatment 
for COVID-19 either via the PIS or HEPMA. We will also 
examine adverse outcomes following COVID-19 infec-
tion: admission to hospital, critical care admission or 
death. Hospital admission or death will be defined on 
the basis of either COVID-19 (laboratory confirmed or 
clinically diagnosed) recorded on a hospital admission 
in SMR01 or death record (using ICD10 codes U07.1, 
U07.2,) or positive test, or admission in RAPID within 14 
days of a SARS- CoV-2 RT- PCR positive test.45 Critical care 
admissions will be defined on the basis of presence on 
the SICSAG database and a relevant hospital admission 
(using ICD10 codes U07.1, U07.2) or positive test.
Statistical analysis
Epidemiology of COVID-19 by ethnicity and social factors
We will describe the epidemiology of COVID-19 by ethnic 
and social factors, specifically in relation to: (1) incidence 
of confirmed SARS- CoV-2 infection; (2) incidence of clin-
ically diagnosed disease and (3) evidence of previous 
infection. We will use summary statistics to describe the 
cohort by presence and absence of confirmed, diagnosed 
and suspected COVID-19. We will perform a descriptive 
analysis of the number of cases by exposure groups in the 
first instance, to determine the level of disaggregation 
feasible. In addition to analysing inequalities by ethnicity 
and social factors, we will also investigate the inequalities 
by country of birth (ie, migration- related inequalities).
Poisson regression with robust standard errors will be 
used to estimate risk ratios for the risk of infection across 
exposure groups. We will consider age and sex to be key 
potential confounders for all analyses, with adjustment 
for LA also planned for most analyses (to account for the 
differential spread of the infection across geographies, 
and local mitigation levels). If case numbers allow, we 
will examine the incidence of confirmed and suspected 
COVID-19 by sex (and for ethnicity, country of birth). 
We can assess whether findings are robust to more strin-
gent definitions of confirmed and suspected infection, 
for example, by restricting the definition of a confirmed 
case to one with positive viral RT- PCR, and restricting the 
definition of a suspected case to exclude people with a 
negative viral RT- PCR result.
Surveillance of preventative treatment and interventions for 
COVID-19 across social and ethnic factors
We will describe treatment for and prevention of 
COVID-19 by ethnicity and other social factors (eg, 
SEP, occupation), especially in relation to vaccination 
uptake. We will tabulate those who have been vaccinated 
as a proportion of the total eligible in different social 
subgroups, from when the vaccine is available and deliv-
ered nationally. This will be monitored over time to inves-
tigate whether there is a change in vaccination rates for 
different subgroups. If we have sufficient numbers of 
people vaccinated, we will also stratify these analyses by 
demographic factors. Similarly, we will also investigate the 
potential ethnic and other social differences in treatment 
for COVID-19 during acute infection and post- COVID via 
GP prescribing or hospital- administered medical care.
Inequalities in risk of adverse health outcomes from COVID-19
We will quantify ethnic and social inequalities in the 
risk of adverse outcomes (hospital admission, critical 
care admission and mortality) from COVID-19. We will 
perform a descriptive analysis of the number of cases by 
exposure group in the first instance, to help determine 
the level of disaggregation feasible. We will follow a previ-
ously published approach46 to analyse COVID-19 survival 
outcomes using Cox proportional hazards models from 
the date of a positive test result (or first date of diagnosis). 
We will conduct sensitivity analyses excluding people resi-
dent in care homes at the study start date. We will consider 
Fine and Gray competing risks models (to account for 
non- COVID-19 deaths) for sensitivity analysis47 or alter-
natively by applying inverse probability weights to address 
competing risks.
Mediation analyses to explore drivers of inequalities in COVID-19
We will explore the contribution of several potential medi-
ators of ethnic and social inequalities in COVID-19. The 
extent of these analyses will be determined by the magni-
tude of any observed inequalities in COVID-19 outcomes. 
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Potential mediators to be investigated for ethnic inequal-
ities include occupation, SEP, cultural factors (such as 
language ability and country of birth) and prepandemic 
health (assessed through census, GP records and hospi-
talisations data). We will conduct cross- tabulations of the 
relationships between exposures, potential mediators and 
outcomes, followed by a set of nested regression models 
for the same purpose. Following this, we will pursue more 
formal mediation analyses. We expect to use G methods,48 
such as marginal structural modelling, to estimate the 
direct and indirect effect of ethnicity mediated through 
the mediating factors. We will investigate the extent to 
which inequalities might arise from differential exposure 
compared with differential susceptibility.49 Our analysis 
will be informed by a Directed Acyclic Graph (figure 2). 
Given we are uncertain about whether the country of 
birth and geography are confounders or mediators, we 
will conduct sensitivity analyses without adjusting for 
these variables. In addition to analysing inequalities by 
ethnicity, we will investigate inequalities by country of 
birth to explore migration- related inequalities. We will 
consider conducting similar mediation analyses for socio-
economic inequalities in COVID-19, depending on the 
extent of inequalities observed.
Effect modification
We will investigate whether interactions exist for key 
combinations of exposure variables, such as ethnicity, 
SEP and occupation. We will study whether occupational 
risks of COVID-19 differ by ethnic group. Occupation will 
be assessed on the basis of Standard Occupational Clas-
sification 2000 codes, aggregated from three- digit codes 
to a level that meets disclosure control requirements. We 
will perform descriptive analysis of the number of cases 
by occupation initially, followed by cross- tabulation by 
ethnicity. We will then estimate relative risks for outcomes 
of interest and check for evidence of effect modification 
on an additive and multiplicative scale. Should we observe 
evidence that occupational risk differs by ethnicity, we will 
calculate relative excess risks due to interaction.50 Similar 
analyses will be conducted to assess potential effect modi-
fication for key combinations of exposure groups, as 
prioritised by our policy partners.
Assessment of quality of ethnicity coding
We will assess the quality of ethnicity coding within NHS 
administrative datasets, in order to assess whether, in the 
absence of Census data, administrative data can be reliably 
used to study ethnic inequalities. We will start by assessing 
the proportion of information on ethnicity missing within 
each dataset. Following this, we will consider the 2011 
Census to be our ‘gold- standard’ dataset for comparison 
purposes. We will quantify the prevalence of different 
ethnic groups within each dataset and assess the sensi-
tivity, specificity, positive predictive value and negative 
predictive value, following the methods used in previous 
validation studies.51 If numbers of cases allow, we will 
stratify analyses by broad age group, sex and country of 
birth.
Sample size
Accounting for non- linkage and non- participation in 
the Census (via migration or birth after the Census or 
otherwise), we estimate that the size of the cohort will be 
4.3 million people. We are confident based on research 
from previous pandemics in similar- sized populations52 
Figure 2 Directed Acyclic Graph of the causal pathways between ethnicity and COVID-19 yellow box: outcome blue box: 
exposure green box: confounder white box with green outline: confounder (unmeasured) white box with blue outline: mediator 
blue arrow: main effect green arrow: confounding light green arrow: unmeasured confounding light blue arrow: mediated effect.
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that there will be sufficient statistical power to perform 
our planned analyses. For example, for the African ethnic 
group which is one of the least frequent ethnic groups 
in Scotland, considering COVID-19 deaths (the least 
common outcome), we anticipate there being approx-
imately 30 COVID-19 deaths from the first wave in the 
African ethnic group which exceeds the number of events 
in previous completed analyses. Utlimately, the total 
number of events is dependent on the trajectory of the 
COVID-19 pandemic in Scotland, and statistical power 
will be assessed on an outcome- by- outcome basis.
Patient and public involvement
An EAVE II Patient and public involvement (PPI) group 
has been established, which includes diverse ethnic and 
socioeconomic representation. Study plans have been 
discussed with the group and this has confirmed the 
importance of investigating a broad range of social factors 
(including SEP, as well as ethnicity). The study design was 
initially developed by the study investigators without PPI 
due to delays in being able to establish the PPI group, 
but more substantive input into the creation of detailed 
analysis plans is now ongoing. Findings will be discussed 
regularly with the group and revised on the basis of their 
input accordingly. The PPI group will also inform the 
development of dissemination plans.
ETHICS AND DISSEMINATION
This study, as part of the wider EAVE II project, has been 
approved by the National Research Ethics Committee, 
South East Scotland 02. The study has also received 
approval from the Public Benefit and Privacy Panel for 
Health and Social Care (2021–0015), and approval from 
the Statistics Public Benefit and Privacy Panel (2021–
0115). Findings from this study will be published in 
peer- reviewed journals and presented at international 
conferences. Analyses will be presented to policy- makers 
within UK and Scottish governments and to relevant 
public health practitioners in Scotland throughout the 
course of the study. Strengthening the Reporting of 
Observational Studies in Epidemiology and Reporting 
of studies Conducted using Observational Routinely- 
collected Data (RECORD) guidelines will be used in 
reporting the findings of the study.
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